Objective-Abdominal aortic aneurysm (AAA) is a complex multifactorial disease associated with a high morbidity and mortality. Increased inflammation including T-helper 17 cell-mediated effects has been implicated in AAA pathogenesis. Psoriasis is considered to be a T-helper 17-driven chronic inflammatory disease and in view of potentially overlapping inflammatory mechanisms, we investigated the risk of AAA in patients with psoriasis in a nationwide cohort. Approach and Results-The study comprised all Danish residents aged ≥18 years followed up from January 1, 1997, until diagnosis of AAA, December 31, 2011, migration or death. Information on comorbidity, concomitant medication, and socioeconomic status was identified by individual-level linkage of administrative registers. Incidence rates for AAA were calculated and incidence rate ratios adjusted for age, sex, comorbidity, medications, socioeconomic status, and smoking were estimated in Poisson regression models. A total of 5 495 203 subjects were eligible for analysis. During the study period, we identified 59 423 patients with mild psoriasis and 11 566 patients with severe psoriasis. The overall incidence rates of AAA were 3.72, 7.30, and 9.87 per 10 000 person-years for the reference population (23 696 cases), mild psoriasis (240 cases), and severe psoriasis (50 cases), respectively. The corresponding adjusted incidence rate ratios for AAA were increased in patients with psoriasis with incidence rate ratios of 1.20 (95% confidence interval, 1.03-1.39) and 1.67 (confidence interval, 1.21-2.32) for subjects with mild and severe disease, respectively. Conclusions-In a nationwide cohort, psoriasis was associated with a disease severity-dependent increased risk of AAA.The mechanisms and consequences of this novel finding require further investigation. Figure, and baseline characteristics for the study population are presented in Table 1.
Risk of AAA in Patients With PsoriasisThe results showed a disease-severity-dependent association between psoriasis and AAA (
Sensitivity AnalysesCensoring of patients who developed atherosclerotic disease during the study and exclusion of patients with atherosclerotic disease before the study start did not alter the risk of AAA in psoriasis patients (
DiscussionIn this retrospective cohort study of the Danish population, we found an increased risk of AAA in patients with psoriasis, independent of traditional cardiovascular risk factors. Notably, the observed risk increased with increasing severity of psoriasis. The results were supported by the sensitivity analyses. To our knowledge, this is the first study to assess the risk of AAA in patients with psoriasis in a nationwide setting. These results may warrant the need for increased awareness on higher risk of AAA in patients with severe psoriasis. Psoriasis is a chronic immune-mediated inflammatory disease associated with cardiometabolic comorbidities. 13,14,17,18 Although it is well-established that psoriasis is an independent risk factor for atherosclerotic disease and persi...